Published in Women's Health Weekly, September 23rd, 2004
A total of 658 patients were studied in this 12-week, randomized, double-blind, placebo-controlled trial, which was included in the new drug application for SANCTURA approved by the U.S. Food and Drug Administration on May 28, 2004. In addition to meeting the endpoints of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.